Top 50 Biotechnology Startup Investors in Austria (September 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
XISTA Science Ventures
VC Fund
|
18 | Austria, Germany, France | Seed, Pre-Seed, Series A | Biotechnology, Medical, Software | $548k–$20M |
|
tecnet equity
VC Fund
|
9 | Austria | Seed, Series A | Software, Biotechnology, Artificial Intelligence | $400k–$20M |
|
xista science ventures
VC Fund
|
9 | Austria, Slovenia | Seed, Pre-Seed, Series A | Biotechnology, Medical, Software | $552k–$20M |
|
austria Wirtschaftsservice (aws)
VC Fund
|
6 | Austria, Belgium | Seed, Grant, Pre-Seed | Software, Information Technology, Artificial Intelligence | $61k–$2.7M |
|
SOSV
VC Fund
|
5 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
aws Gründungsfonds
VC Fund
|
4 | Austria, Germany, United States | Seed, Series A | Software, SaaS, Information Technology | $1.1M–$11M |
|
MIG Capital
VC Fund
|
4 | Germany, France, Austria | Series A, Series B, Seed | Biotechnology, Health Care, Software | $1.3M–$60M |
|
Arax Capital Partners
VC Fund
|
3 | Austria, United States | Seed, Venture - Series Unknown, Series A | Biotechnology, Software, Health Care | $600k–$10M |
|
FPS-Holding
VC Fund
|
3 | Austria | Seed | Biotechnology, Health Diagnostics | $420k–$1.5M |
|
PUSH VC
VC Fund
|
3 | Austria, Germany, United States | Seed, Series A | Software, Apps, Health Care | $650k–$31M |
|
Lansdowne Partners
VC Fund
|
3 | United Kingdom, Austria, United States | Series A, Series B | Biotechnology, Finance, Genetics | $6.7M–$100M |
|
10x Founders
VC Fund
|
3 | Germany, United States, Switzerland | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Information Technology | $620k–$53M |
|
Longevitytech.fund
VC Fund
|
2 | United States, United Kingdom, The Netherlands | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Life Science | $100k–$10M |
|
bmp Ventures
VC Fund
|
2 | Germany, United States, Austria | Seed, Series A | Software, Information Technology, Manufacturing | $162k–$5.9M |
|
Aescap Venture
VC Fund
|
2 | Switzerland, United Kingdom, The Netherlands | Series B, Series A, Series C | Biotechnology, Pharmaceutical, Health Diagnostics | $1.5M–$33M |
|
APEX Ventures
VC Fund
|
2 | Germany, United Kingdom, Austria | Seed, Series A, Pre-Seed | Artificial Intelligence, Software, Health Care | $552k–$22M |
|
R42 Group
VC Fund
|
2 | United Kingdom, United States, Austria | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Software | $472k–$40M |
|
Simon Capital
VC Fund
|
2 | Germany, Austria, The Netherlands | Series A, Seed, Series B | Software, Biotechnology, Food and Beverage | $1.7M–$57M |
|
Nina Capital
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $529k–$21M |
|
MCI Capital SA
VC Fund
|
2 | Poland, United Kingdom, Germany | Series A, Venture - Series Unknown, Series C | E-Commerce, Software, Financial Services | $603k–$45M |
|
The Austrian Research Promotion Agency (FFG)
VC Fund
|
2 | Austria, United States, Belgium | Grant, Seed, Pre-Seed | Software, Artificial Intelligence, Medical | $67k–$3.5M |
|
SkyGene
VC Fund
|
2 | Austria | Venture - Series Unknown | Medical, Health Care, Biotechnology | |
|
Axilium Holding
VC Fund
|
2 | Sweden, Austria | Seed, Venture - Series Unknown | Software, Human Resources, FinTech | $450k–$7.3M |
|
VP Venture Partners
VC Fund
|
2 | Austria, Switzerland | Seed | Medical, Health Diagnostics, Internet | $3M–$6.9M |
|
Open Field Capital
VC Fund
|
2 | United States, Austria, United Kingdom | Venture - Series Unknown, Series A, Seed | Artificial Intelligence, Software, Machine Learning | $150k–$350M |
|
Schnidar Harald
Angel
|
2 | Austria | Seed, Angel, Pre-Seed | Software, Biopharma, Cosmetics | |
|
TSVC
VC Fund
|
2 | United States, China, Canada | Seed, Series A | Software, Artificial Intelligence, Health Care | $500k–$44M |
|
Verge HealthTech Fund
VC Fund
|
2 | Estonia, Singapore, United States | Seed, Pre-Seed, Series A | Health Care, Medical, Medical Device | $500k–$4.7M |
|
Ligand Pharmaceuticals
VC Fund
|
2 | United States, Austria, Denmark | Post-IPO Debt, Corporate Round, Post-IPO Equity | Biotechnology, Medical, Health Care | $3M–$90M |
|
Übermorgen Ventures
VC Fund
|
2 | Germany, Switzerland, Finland | Seed, Pre-Seed, Series A | Energy, Software, SaaS | $300k–$12M |
|
ICL Planet Startup Hub
VC Fund
|
2 | Israel, Austria | Seed | Biotechnology, Agriculture, AgTech | $4.3M–$10M |
|
GreyBird Ventures
VC Fund
|
2 | United States, Germany, China | Series A, Seed | Health Care, Medical, Biotechnology | $3M–$16M |
|
KHAN Technology Transfer Fund
VC Fund
|
2 | Germany, Austria, Belgium | Seed, Pre-Seed, Series A | Biotechnology, Medical, Biopharma | $259k–$10M |
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
2 | Germany, Switzerland, United States | Seed, Series A | Software, Biotechnology, Information Technology | $850k–$31M |
|
Gamma Capital Partners
VC Fund
|
2 | Austria, United States, Germany | Series A, Seed | Software, Manufacturing, Information Technology | $409k–$8M |
|
BackBone Ventures
VC Fund
|
2 | Switzerland, Germany, Israel | Pre-Seed, Seed, Series A | Artificial Intelligence, Software, Information Technology | $578k–$105M |
|
red-stars.com
VC Fund
|
2 | Austria, Germany | Seed, Venture - Series Unknown | Software, Biotechnology, Telecommunications | $1.1M–$4.4M |
|
eQventure
VC Fund
|
2 | Austria, Germany, Switzerland | Seed, Series A, Series B | Software, Information Technology, Automotive | $540k–$13M |
|
Hadean Ventures
VC Fund
|
2 | Sweden, Norway, Austria | Series A, Series B, Venture - Series Unknown | Biotechnology, Health Care, Medical | $2M–$79M |
|
Andera Partners
VC Fund
|
1 | France, United States, Germany | Series B, Private Equity, Series A | Biotechnology, Health Care, Medical | $7M–$237M |
|
FCPG Affi
VC Fund
|
1 | Austria | Venture - Series Unknown | Medical, Biotechnology, Pharmaceutical | |
|
4SC
VC Fund
|
1 | Austria | Seed | Health Care, Biotechnology | |
|
FastVentures
VC Fund
|
1 | Hungary, South Korea, United States | Seed, Series A, Series B | Software, Biotechnology, Health Care | $473k–$34M |
|
PONTIS Venture Partners Management
VC Fund
|
1 | Austria, Germany | Series A, Series B, Series C | Software, Manufacturing, Information Technology | |
|
IPO Beteiligungs-Management
VC Fund
|
1 | Austria | Series B | Sensor, Medical, Wireless | |
|
IBG Beteiligungsgesellschaft Sachsen-Anhalt
VC Fund
|
1 | Germany, Austria | Seed, Series A | Electronics, Software, Medical Device | |
|
ReGen Ventures
VC Fund
|
1 | United States, Austria, United Kingdom | Seed, Series A, Series B | Agriculture, Biotechnology, Farming | |
|
HBM Partners
VC Fund
|
1 | United States, Germany, Switzerland | Series B, Series C | Biotechnology, Medical, Health Care | $2.5M–$125M |
|
Clima Now
VC Fund
|
1 | Switzerland, Germany, Austria | Seed, Grant, Pre-Seed | Farming, Renewable Energy, Solar | |
|
Gateway Ventures
VC Fund
|
1 | Germany, Austria, Estonia | Seed, Series A | Software, Information Technology, Apps | |
| Access all 169 investors in Austria Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more...Investment focus
- Industry: Biotechnology, Medical, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Austria, Germany, France
Investor stats
- Total investments: 47
- Round size: Seed $1.8M–$6.9M; Pre-Seed $548k–$1.7M; Series A $5.7M–$20M
- Lead/follow: 57% lead, 43% follow
Portfolio highlights
- Rivus Batteries — Rivus is a start-up that serves as the commercialization platform for the aqueous organic flow battery technology.
- Ora Computing — We make AI models smaller, faster, and more efficient.
- Epitome Therapeutics — Epitome Therapeutics is an early-stage biotechnology company developing CADENCE, a next-generation epigenome editing platform for precise, durable, and context-dependent control of gene expression without altering the underlying DNA sequence, with the aim of establishing a new therapeutic modality for diseases driven by dysregulated gene activity.
tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.
Show more...Investment focus
- Industry: Software, Biotechnology, Artificial Intelligence
- Stage:Seed, Series A
- Geography: Austria
Investor stats
- Total investments: 76
- Round size: Seed $400k–$2.5M; Series A $557k–$20M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $33M in 2009
Portfolio highlights
- PROPCORN AI — At PROPCORN, our goal is to harness the power of AI to automatically unlock the full real estate building potential of our customers, enabling them to make faster and more accurate decisions in real-time.
- deepentix — Deepentix provides a graph-as-a-service platform that converts unstructured documents into verifiable claim graphs. Its software extracts semantic claims, qualifiers, constraints, and confidence information, then links entities to domain ontologies. The Claim Graph API supports natural-language and API-based queries with paragraph-level citations,conflict flags, policy checks, and provenance paths. Private extractors use domain-tuned small language models for organization-specific templates and terminology. Deepentix also offers hosted and on-premises graph deployments that can integrate with systems such as electronic laboratory notebooks, laboratory information management systems, claims systems, and chat copilots. The platform is intended for regulated workflows in life sciences, insurance, legal and regulatory work, and climate and ESG analysis where document-based decisions require traceability and audit records.
- VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more...Investment focus
- Industry: Biotechnology, Medical, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Austria, Slovenia
Investor stats
- Total investments: 22
- Round size: Seed $1.8M–$7.3M; Pre-Seed $552k–$1.5M; Series A $5.7M–$20M
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- subdron — subdron turns the seabed from a blind spot into a monitored domain.
- infrared.city — Redefine environmental simulations. Our bespoke AI models revolutionise performative design, slashing time, cost, and complexity. Access cutting-edge services effortlessly because innovation should be for everyone
- VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
The Austrian Economic Service mbH (aws) is the promotional bank of the Federal Government.The aws SME fund is the largest Austrian Fund for silent corporate investments, but also providers of equity. Founded in late 2009 by the Austrian Economic Service mbH (aws) - the Development Bank of the Federal - he has a term until 31/12/2025.The fund is currently endowed with EUR 80 million and participates in medium-sized companies and brings with it a fresh capital to develop new products or processes, for sales development to international expansion.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Grant, Pre-Seed
- Geography: Austria, Belgium
Investor stats
- Total investments: 76
- Round size: Seed $452k–$2.7M; Grant $61k–$2.3M; Pre-Seed $195k–$1.6M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $92M in 2013
Portfolio highlights
- Repentium — We strive to create
- Graph Therapeutics — Graph Therapeutics - precision immunology
- Epitome Therapeutics — Epitome Therapeutics is an early-stage biotechnology company developing CADENCE, a next-generation epigenome editing platform for precise, durable, and context-dependent control of gene expression without altering the underlying DNA sequence, with the aim of establishing a new therapeutic modality for diseases driven by dysregulated gene activity.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
aws Gründerfonds is Austria's 70m venture capital fund. We invest as co-investor in Austrian high-growth start-ups in their later seed and (pre-)series-A stages.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A
- Geography: Austria, Germany, United States
Investor stats
- Total investments: 100
- Round size: Seed $1.3M–$5.2M; Series A $1.1M–$11M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely still investing — raised $77M in 2023
Portfolio highlights
- refinq — Asset-level climate and nature risk analytics for banks, insurers and corporates. Audit-ready data for CSRD, EU Taxonomy, EBA Pillar 3, SFDR and TNFD.
- vitrealab — Enlighten. Your perspective. Light Engines for AR glasses.
- Invisible-Light Labs — Invisible Light Labs uses Fourier transform infrared (FTIR) spectroscopy and nanoelectromechanical sensing technologies to enable chemical analysis of materials and nanomaterials that are available in minuscule amounts in a variety of industries, from environmental monitoring to pharmaceuticals.
MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These fundsoperate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria.Today, our portfolio consists of 30 companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series A, Series B, Seed
- Geography: Germany, France, Austria
Investor stats
- Total investments: 98
- Round size: Seed $1.3M–$13M; Series A $2.2M–$40M; Series B $1.7M–$60M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — raised $76M in 2014
Portfolio highlights
- NcodiN — The High Performance Computing (HPC) and ArtificiaI Intelligence (AI) era requires unprecedented computing capabilities. With this in view, industry is heading towards zettascale supercomputers, based on >100k processing units. Chiplets-based disaggregated processors and memory-centric computing architectures are taking over and require an ever more intensive communication between dies. Thus, today interconnect bottleneck is the main
- GlassPoint Solar — GlassPoint provides solar steam generators to the oil and gas industry for applications such as Enhanced Oil Recovery. It replaces gas-fired steam generation with solar, GlassPoint can reduce EOR gas consumption by up to 80 percent. The company was founded in 2008 and headquartered in Fremont, California.
- Zadient Technologies — Zadient produces semiconductor manufacturing materials that are critical for the entire silicon carbide (SiC) value chain
ARAX Capital Partners is an Austrian bio-tech and high-tech early stage investor with an exclusive focus on Austrian ventures. Companies need to be young, innovative (if possible with patentable technology) and must have already secured pre-seed funding to qualify for an investment
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Austria, United States
Investor stats
- Total investments: 11
- Round size: Seed $687k–$1.1M; Venture - Series Unknown $600k–$10M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — raised $88M in 2008
Portfolio highlights
- Greenpass — Greenpass is an all-in-one SaaS for climate-resilient urban planning & architecture platform that enables livable cities.
- Calyxha Biotechnologies — A new perspective on inflammation
- EveliQure Biotechnologies GmbH — EveliQure was founded in 2012 with headquarters in Vienna and developed for the first time a combined vaccine, which is intended to protect against Shigella as well as against ETEC bacteria. Both bacterial strains cause various types of diarrheal diseases, and all attempts at development of vaccines have so far only aimed to protect against one ofthe two bacterial strains. The team led by Managing Director Gábor Somogyi has succeeded for the first time in producing a combined swallow vaccine that simultaneously protects against both bacterial strains.
SPV
Show more...Investment focus
- Industry: Biotechnology, Health Diagnostics
- Stage:Seed
- Geography: Austria
Investor stats
- Total investments: 3
- Round size: Seed $420k–$1.5M
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Sola Diagnostics — Product: Sola Diagnostics’ WID®-easy test is a non-invasive epigenetic solution for detecting endometrial cancer in women with abnormal uterine bleeding. By analyzing DNA methylation markers from a simple vaginal swab, it offers high accuracy, reducing false positives and unnecessary surgeries. Target Audience: Designed for gynecologists andhealthcare providers, WID®-easy streamlines diagnostics, cutting costs and false alarms. Women benefit from a painless, accessible test that ensures earlier and more precise detection. Technology: Powered by advanced DNA methylation research, WID®-easy identifies cancer-specific epigenetic markers. With PCR-based analysis and robust clinical validation, it delivers fast, reliable results that integrate seamlessly into medical workflows. Market Positioning: WID®-easy fills a critical gap as a first-line diagnostic for abnormal uterine bleeding. Its clinical validation, accuracy, and cost-efficiency set it apart from invasive procedures. Its ease of use and scalability position it for widespread adoption. Milestones: Sola Diagnostics launched in Austria and Switzerland in 2024 and expanded to Great Britain in 2025. UKCA Marking was registered in December 2024. So far, private equity investments totaling €2.4M have supported Sola's mission to revolutionize women’s health diagnostics.
We are an early-stage Venture Capital Firm investing in outstanding teams with convincing products and high growth potential.
Show more...Investment focus
- Industry: Software, Apps, Health Care
- Stage:Seed, Series A
- Geography: Austria, Germany, United States
Investor stats
- Total investments: 46
- Round size: Seed $650k–$8.1M; Series A $5M–$31M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — raised $11M in 2019
Portfolio highlights
- Voltrac — Building electric autonomous vehicles for farming & frontline logistics
- enspired — Revolutionize battery storage with AI-powered BESS optimization. Our energy trading platform ensures smart, real-time market access. Contact us today!
- Aitiologic — A precision medicine startup providing multi-modal liquid biopsy solutions for early disease detection and targeted therapy.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Fundamental Equity Investing, since 1998
Show more...Investment focus
- Industry: Biotechnology, Finance, Genetics
- Stage:Series A, Series B
- Geography: United Kingdom, Austria, United States
Investor stats
- Total investments: 46
- Round size: Series A $6.7M–$55M; Series B $9.1M–$100M
- Lead/follow: 20% lead, 80% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- MoA Technology — We harness the principles of natural selection to accelerate discovery for better, safer herbicides so farmers can continue to feed the world.
- GALLOS Technologies — GALLOS is a company that co-builds & invests in security technology companies. Guiding security technology innovators to long-term success
- amnis — Check out your possibilities to transfer money abroad, collect international payments and exchange currencies all in one account. Make payments fast with amnis.
Cutting-edge venture capital firm supporting the early-stage entrepreneurs building global businesses.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United States, Switzerland
Investor stats
- Total investments: 94
- Round size: Seed $2.5M–$10M; Pre-Seed $620k–$5M; Series A $6.7M–$53M
- Lead/follow: 15% lead, 85% follow
- Last fund: Likely still investing — raised $168M in 2022
Portfolio highlights
- Logicc — Logicc provides business solutions for various industries. It specializes in software development, automation, and data-driven technologies.
- Qorelo — Qorelo is a tech company that provides agentic AI software designed to accelerate ERP transformations. Qorelo's software automates and structures deliverables across the SAP Activate methodology.
- Arlequin AI — Unlock actionable insights from complex social data to drive strategic decisions using our AI models.
Investing globally in technologies extending healthy lifespans
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 56
- Round size: Seed $634k–$10M; Pre-Seed $100k–$3.6M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Whytics — DAGI: higher-level causal models from spatiotemporal coarse‑graining Whytics builds tools to reveal and validate macro‑causal structure—the stable, higher-level variables that appear when many parts of a system interact across space and time.
- Klothea Bio — Klothea Bio is a protein well known for its powerful anti-aging capabilities, such as tumor suppression, neuroprotection, and antioxidative actions. As people age, their klotho levels drop to harmful levels. The metabolic disease syndrome will be the focus of the first investigations, while later studies will try to extend therapeutic applicationsto cancer, Alzheimer's disease, obesity, and other age-related diseases.
- Yuva Biosciences — Using cutting edge mitochondrial science to develop cosmeceuticals and pharmaceuticals.
bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Series A
- Geography: Germany, United States, Austria
Investor stats
- Total investments: 122
- Round size: Seed $162k–$3.6M; Series A $912k–$5.9M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely actively investing — fresh fund, raised $70M in 2024
Portfolio highlights
- Lab Thunder — LabThunder provides a cloud-based laboratory management software platform designed to digitize operational workflows. The system centers on centralizing equipment management, automated maintenance scheduling, digital logbooks, and AI-supported knowledge management to ensure audit-ready compliance.
- Sedivention — Fight obesity within 20 minutes - fast, effective, long-term. A new weight-loss therapy for the treatment of obesity. Just a view minutes will change your life.
- Solar Materials — Solar Materials primarily engages in the development of technologies for the sustainable and economical recycling of solar modules.
Aescap Venture is an Amsterdam-based investment company that pursues investments in biotech companies in Europe and the U.S.
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Health Diagnostics
- Stage:Series B, Series A, Series C
- Geography: Switzerland, United Kingdom, The Netherlands
Investor stats
- Total investments: 20
- Round size: Series A $1.5M–$20M; Series B $5.2M–$33M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- Orphazyme — Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases, and is based on discoveries emerging from the academic laboratory of its scientific founders: Professor Marja Jäättela and Thomas Kirkegaard Jensen from the Danish Cancer Society (Kræftens Bekæmpelse).Orphazyme is based in Copenhagen and has established collaborations with top-tier academic institutions in Europe and USA.
- Affectis Pharmaceuticals — Affectis is a pharmaceuticals company developing novel drugs for the treatment of neurodegenerative and neuroinflammatory diseases.
- F-Star Therapeutics — F-star is a clinical stage biotech developing next generation immunotherapies to transform the lives of patients with cancer. We are developing transformational cancer immunotherapies for patients who have few remaining options.
APEX Ventures is a deep-tech and medical focused venture capital firm, run by founders with complimentary backgrounds driven by the same mission.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United Kingdom, Austria
Investor stats
- Total investments: 53
- Round size: Seed $1.4M–$8M; Pre-Seed $552k–$9.1M; Series A $2.4M–$22M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
- HyperHeat — HyperHeat is building a cutting-edge, all-electric heating solution designed to reach temperatures of up to 2,000°C. Using renewable electricity HyperHeat is providing an efficient alternative to fossil fuel combustion. With an efficiency rate of up to 98%, HyperHeat is ideal for retrofitting industrial processes, enabling significant CO2reductions across industries like steel, cement, and chemicals. The scalable technology offers a cost-efficient approach to decarbonizing thermal processes, with a potential to reduce global CO2 emissions by over 4.5 gigatons annually.
- TriLite Technologies — The world's smallest projection displays from TriLite take laser beam scanning technology to the next level, for augmented vision as light as the eyewear of today.
R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Austria
Investor stats
- Total investments: 35
- Round size: Seed $754k–$8M; Pre-Seed $472k–$2M; Series A $4.2M–$40M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely actively investing — fresh fund, raised $5.3M in 2025
Portfolio highlights
- xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
- Stamp Free — stampfree.ai Digital Shipping Solutions enables customers to send parcels and returns with just a phone conveniently and securely.
- Cordance Medical — Improving outcomes for patients with brain diseases
Simon Capital is an early-stage VC fund with €105M capital ready to invest in innovations that will improve our everyday lives, following the mission of investing “for the next generation”.
Show more...Investment focus
- Industry: Software, Biotechnology, Food and Beverage
- Stage:Series A, Seed, Series B
- Geography: Germany, Austria, The Netherlands
Investor stats
- Total investments: 22
- Round size: Seed $1.8M–$9.3M; Series A $1.7M–$14M; Series B $32M–$57M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — raised $110M in 2022
Portfolio highlights
- VisioLab — Instantly scan products for self-checkout, using the iPad camera - no barcodes needed. Designed for speed, simplicity and human centricity.
- Pacifico Biolabs — Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of sustainable and food alternatives.
- dsb Deutsche Sanierungsberatung — dsb Deutsche Sanierungsberatung provides easy and sustainable solutions for climate-friendly homes energy-efficient renovations for homeowners.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 96
- Round size: Seed $2M–$6.3M; Pre-Seed $529k–$2.4M; Series A $5M–$21M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fresh fund, raised $52M in 2025
Portfolio highlights
- Biobase — Biobase is the agentic system for clinical data, closing the gap between clinical data and better healthcare.
- Ladder Health — Ladder Health offers virtual pediatric therapy and support for early childhood developmental delays, including speech and physical therapy.
- Woodway Assurance — Woodway Assurance provides EviData, an AI-driven software for automated privacy assurance on de-identified and synthetic datasets.
MCI Capital is a leading Digital Private Equity investor in CEE, based in Warsaw, Poland. MCI Capital seeks to invest in digital disruption, transformation and infrastructure within EU, with focus on CEE. Preferred sectors are SaaS, E-commerce, Marketplace, Fintech, Insurtech, Foodtech, Traveltech and Digital Infrastructure. MCI typically investsEUR 25-100 M in a single project, either in Buyout or Expansion stage. Historically, MCI Capital has also been involved in funds dedicated to Private Debt, Growth and Venture Capital areas – these funds do not conduct any new investments, instead they focus on building the value of assets and de-investing.MCI Capital is managed by the executive management team. The company is listed on the Warsaw Stock Exchange since February 2001 and is also a member of the Polish Private Equity Association.
Show more...Investment focus
- Industry: E-Commerce, Software, Financial Services
- Stage:Series A, Venture - Series Unknown, Series C
- Geography: Poland, United Kingdom, Germany
Investor stats
- Total investments: 57
- Round size: Series A $603k–$9.6M; Series C $5.5M–$45M; Venture - Series Unknown $798k–$11M
- Lead/follow: 63% lead, 37% follow
- Last fund: May invest from a new fund soon — raised $15M in 2011
Portfolio highlights
- Windeln.de — windeln.de, together with its subsidiaries, operates as an online retailer of products for babies, toddlers, children, and young mothers in Germany, Austria, Switzerland, the Czech Republic, Spain, and China. It operates through German Shop, International Shops, and Shopping Clubs segments. The company offers a range of products, including diapers,baby food, drugstore products, clothes, toys, strollers, child car seats, baby monitors, and children’s furniture.
- ANSWEAR.com — 200 fashion brands with free delivery in 24h!
- Telematics Technologies — Telematics Technologies sp. z o.o., a Polish technology company, until December 2017 operating as NaviExpert sp. z o.o. The company is a leading provider of insurance telematics and premium navigation solutions for smartphones on the Polish market. The company's portfolio also includes, among others, a system for managing fleets of vehiclesup to 3.5 tonnes called NaviExpert Telematics. In terms of telematics insurance, since 2015 Telematics Technologies has been working with PZU Group, which is one of the largest financial groups in Central and Eastern Europe. As a result of cooperation between the entities, the first offers of Usage-Based Insurance appeared on the Polish market (Safe driving with LINK4, LINK4 Cash Returns) as well as offers of accident detection and reconstruction (PZU GO). Individual customers know Telematics Technologies primarily as a navigation application provider NaviExpert. The application is available on the market under its own brand, as well as in a white label model in offers of all mobile network operators in Poland as Navigation Orange, Navigation Play, Navigation Plus, Navigation T-Mobile. Every month, the system is used by nearly 600 thousand paying users. The company creates solutions that aim to increase road safety by improving drivers' driving styles. Since 2012, the company's CEO has been Adam Bąkowski. The majority shareholder of Telematics Technologies company is Noble Fund Private Debt Fundusz Inwestycyjny Zamknięty Aktywów Niepublicznych with its registered office in Warsaw.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!The Austrian Research Promotion Agency (FFG) is the national funding agency for industrial research and development in Austria. As a "one-stop shop" offering a diversified and targeted programme portfolio, the FFG gives Austrian businesses and research facilities quick and uncomplicated access to research funding.The FFG was foundedon 1 September 2004 (pursuant to the FFG Act on establishing a research promotion agency, Federal Law Gazette I No. 73/2004). The FFG is wholly owned by the Republic of Austria, represented by the Federal Ministry for Transport, Innovation and Technology (bmvit) and the Federal Ministry of Science, Research and Economy (BMWFW). As a provider of funding services, however, the FFG also works for other national and international institutions.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Medical
- Stage:Grant, Seed, Pre-Seed
- Geography: Austria, United States, Belgium
Investor stats
- Total investments: 70
- Round size: Seed $300k–$2.2M; Grant $67k–$3.5M; Pre-Seed $480k–$1.9M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- OPTIMUSE — Optimuse provides an AI-based solution that supports the pre-design phase of building renovation. The platform converts building data into a digital twin to create accurate models for planning. It integrates data such as room types, thermal properties, and HVAC systems. The system runs energy simulations to calculate heating, cooling, lighting, andequipment needs. It helps design technical systems by defining the quantity, sizing, and configuration of components. The platform develops renovation plans by modeling financial, energy, and emissions outcomes. It also offers tools for cost calculation, performance monitoring, and collaboration across project teams.
- sequestra — Sequestra is developing a technology platform that allows for permanent binding of CO₂ in industrial residues such as steel slag, incineration ash, and demolition waste while making the carbonated materials usable for construction applications.
- Another Earth — Another Earth is building an AI-powered simulation and synthetic data platform for Earth Observation. As our planet changes, AI models need scalable, high-quality training data to keep pace. Another Earth provides synthetic data, scenario simulations and predictions required to accelerate AI development, and enable faster, smarterdecision-making—enabling smarter decisions for a more resilient world.
SkyGene is a venture capital firm. The firm intends to invest in biotech firms.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Venture - Series Unknown
- Geography: Austria
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Axilium Holding
Show more...Investment focus
- Industry: Software, Human Resources, FinTech
- Stage:Seed, Venture - Series Unknown
- Geography: Sweden, Austria
Investor stats
- Total investments: 4
- Round size: Seed $450k–$7.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Planacy — Planacy is a modern and flexible planning platform that is built to handle a complex reality. With Planacy you will get a tailor-made platform that is adjusted just for your business needs, a platform that you can easily develop when your prerequisites changes. By smart and seamless integrations to your BI platforms from Power BI®, Qlik® orTableau®, Planacy decreases the time consuming manual and repetitive work and supports your business with a fast, safe, more collaborative and flexible process. Together with an intuitive and smooth user interface your planning process will be simpler and more fun with more time to spend on the more value creating work as a result.
- Sarcura — Sarcura GmbH is an Austrian deep-tech startup developing an instrument platform for the industrial manufacturing of advanced cell therapies. Our platform combines silicon chip technology and microfluidic processing to enable real-time process control and manipulation on a cellular level, enabling a fully automated and modular manufacturing system..
- WorkNode — Worknode is shaping the future of work. With modern technology and a deep understanding of labor market dynamics, we make flexible work safe, simple, and sustainable for both individuals and companies.For individuals, Worknode enables earning and getting paid like an employee without starting a company. For businesses, we provide a digitalemployer-of-record service that streamlines the management of external talent with full compliance, transparency, and efficiency.By building the digital infrastructure for a more flexible workforce, Worknode creates new opportunities for people to shape their careers and for companies to scale with the right skills at the right time. More than a platform, Worknode is a partner in driving a modern, dynamic, and inclusive way of working.
VP Venture Partners is a venture capital firm invests in healthcare companies.
Show more...Investment focus
- Industry: Medical, Health Diagnostics, Internet
- Stage:Seed
- Geography: Austria, Switzerland
Investor stats
- Total investments: 7
- Round size: Seed $3M–$6.9M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Diamens — Diamens is a company focused on femtech that develops a non-invasive menstrual blood-based molecular diagnostic to detect women-specific diseases like endometriosis.
- Moonlight AI — Moonlight AI was created to democratize the access to genomic information that is essential for therapy decision making in the era of personalized medicine.
- CollimateHealth — CollimateHealth is creating a clinically scalable microbeam radiation technology that will revolutionize the treatment of cancer.
Open Field Capital
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Venture - Series Unknown, Series A, Seed
- Geography: United States, Austria, United Kingdom
Investor stats
- Total investments: 32
- Round size: Seed $3.1M–$30M; Series A $8.7M–$350M; Venture - Series Unknown $150k–$6.2M
- Lead/follow: 0% lead, 100% follow
- Last fund: Likely actively investing — fresh fund, raised $2.3M in 2024
Portfolio highlights
- Groq — Groq is a technology company that designs and provides specialized artificial intelligence compute solutions focused on accelerating AI inference workloads using its custom-built Language Processing Unit (LPU) hardware and associated software stack. The company’s core products include purpose-designed silicon and cloud-accessible platforms thatsupport real-time execution of large language models and other AI tasks with low latency and high throughput, enabling developers and enterprises to integrate AI services into production environments efficiently. Groq also delivers cloud-based services that allow customers to access inference capabilities via APIs compatible with popular development tools, supporting seamless integration into existing AI workflows. Its engineering efforts emphasise deterministic performance and streamlined deployment, targeting use cases where speed and cost predictability are critical. Groq engages with partners and customers across sectors that require rapid AI inferencing, and the company’s technology has attracted significant strategic interest and investment within the broader AI infrastructure ecosystem.
- Numenta — Powerful, Neuroscience-Based AI
- Paragraf — We Work to Develop Innovative and Useful End Products from Novel Materials. Our Analogue Sensors Are Designed to Provide Accurate Field Gradient Mapping & Alignment.
Entrepreneur, Angel Investor, Scientist and Inventor
Show more...Investment focus
- Industry: Software, Biopharma, Cosmetics
- Stage:Seed, Angel, Pre-Seed
- Geography: Austria
Investor stats
- Total investments: 7
- Lead/follow: 86% lead, 14% follow
Portfolio highlights
- SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.
Founded in 2010, TSVC (formerly TEEC Angel Fund) is proud to be a leading early-stage venture capital fund in Silicon Valley.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A
- Geography: United States, China, Canada
Investor stats
- Total investments: 341
- Round size: Seed $500k–$6.3M; Series A $2.7M–$44M
- Lead/follow: 7% lead, 93% follow
- Last fund: Likely actively investing — fresh fund, raised $20M in 2026
Portfolio highlights
- Nvigen — NVIGEN is revolutionizing personalized medicine with highly accurate and NGS data efficient assays that provide integrative DNA, RNA, protein, cell, exosome information. Our mission is to improve health through our open platform of molecularly engineered nanoparticles and data-driven insights that help understand biological processes and reduce risks for aging, cancer, cardiovascular, neurodegenerative, and diabetic conditions.The NVIGEN X - Cancer Precision Profiling Test, now available for research use, supports early detection, monitoring, and treatment of cancer through accessible liquid biopsy tests. In line with our OpenVigen philosophy, we offer MagVigen and MyQuVigen nanoparticles to the biotech community, enabling high-sensitivity and high specificity immunoassays, genomic testing, molecular and cellular capture, and multiomics analysis. These products empower advancements in biomarker profiling, point-of-care testing, T-cell therapy, and precision diagnostics.
- Dexmate — Dexmate is a robotics startup focused on developing general-purpose mobile robots. The company specializes in robots with manipulation capabilities. Their technology aims to enhance automation across various industries.
- EGI Battery — EGI Battery is an American advanced battery cell manufacturer headquartered with design and operations in Ann Arbor, Michigan, U.S.
We make early investments in global healthcare technology companies that address prevention, disease management and health system efficiency that are relevant to emerging AsiaWe believe that innovation can happen anywhere, from the streets of Dhaka to the labs of Oxford, however without the right support network, these solutions might notscale, or find the best world-changing application. This is where we can help.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Pre-Seed, Series A
- Geography: Estonia, Singapore, United States
Investor stats
- Total investments: 30
- Round size: Seed $500k–$4.7M; Pre-Seed $520k–$1M
- Lead/follow: 57% lead, 43% follow
- Last fund: Likely still investing — raised $250k in 2023
Portfolio highlights
- THINKMD — THINKMD develops next-generation clinical assessment and data analytics platforms that transform point-of-care medicine by putting medically validated clinical assessment capability into the hands of non-healthcare professionals. This technology allows for the decentralization of healthcare delivery into communities and homes by pairing clinicalknowledge and Bayesian/pattern recognition algorithms with simple to use mobile technology. Its goal is to reinvent the healthcare delivery paradigm, reduce costs, and improve outcomes by improving healthcare access and care-seeking behavior while building a public health knowledge database.
- Understanding Zoe — One calm home that remembers for you and grows with your family. Built in Australia for families raising neurodivergent children. Try free for 7 days.
- Neuraworx Medical Technology — Neuraworx Medical Technology is a neurotechnology company developing first-in-class bioelectronic solutions for brain health.
A genetic medicines company developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Post-IPO Debt, Corporate Round, Post-IPO Equity
- Geography: United States, Austria, Denmark
Investor stats
- Total investments: 19
- Round size: Post-IPO Debt $15M–$85M; Corporate Round $3M–$10M; Post-IPO Equity $15M–$90M
- Lead/follow: 58% lead, 42% follow
Portfolio highlights
- Agenus — Activating the Power of the Immune System to Defeat Cancer
- Zerion Pharma — Zerion Pharma is a pharmaceutical company that aims to transform the pharmaceutical landscape with a new formulation technology. The company is focused on improving existing drugs by building an internal pipeline to solve the most challenging drug solubility problems that pharmaceutical companies face. Zerion Pharma was founded in 2019 and isbased in Birkerød, Denmark.
- Castle Creek Biosciences — Dedicated to making life better for people suffering from rare diseases with few or no treatment options
We are an early stage VC for climate tech startups.
Show more...Investment focus
- Industry: Energy, Software, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Switzerland, Finland
Investor stats
- Total investments: 55
- Round size: Seed $2.1M–$5.9M; Pre-Seed $300k–$4.1M; Series A $2.5M–$12M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Ecair — Ecair provides software for indoor air quality and energy management. The platform aggregates data from connected sensors to track pollutants, CO2, humidity, temperature, and particulate matter in real time. Dashboards, alerts, and APIs support building operations, facility managers, and ESG teams. Algorithms estimate exposure, flag ventilationissues, and suggest HVAC adjustments to balance comfort, health, and energy use. Reporting tools support certifications and compliance, and data exports integrate with BMS, CMMS, and data warehouses. Services include device provisioning, calibration management, and analytics consulting for multi-site portfolios.
- Verna — Verna is a business using geospatial data science to address the climate and nature crises.We help landowners, investors, and policymakers to use land in ways that draw down carbon, enhance biodiversity and generate sustainable returns – e.g. through woodland creation, habitat creation and enhancement, and regenerative agriculture.Verna wasestablished in Borehamwood, Hertford.
- Hyperion Robotics — We are accelerating the transition to sustainable and automated construction with Concrete 3D Printing.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!ICL Startup Accelerator focuses on foodtech and crop nutrition startups, innovative products, and accelerates their market penetration
Show more...Investment focus
- Industry: Biotechnology, Agriculture, AgTech
- Stage:Seed
- Geography: Israel, Austria
Investor stats
- Total investments: 4
- Round size: Seed $4.3M–$10M
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Agrematch — Agrematch is a data driven small molecules product discovery, development and marketing company, catering to the agricultural industry. Our novel Ag products discovery engine utilizes big-data science, biology, chemistry, and ag know-how to bring new crop protection products to market.
- Lavie bio — LaVie Bio develops bacterial compositions that are sprayed on plants, used to coat seeds, or are integrated in the soil around the plant in order to improve the crop or the plant's features.
- Arkeon Biotechnologies — Arkeon converts CO2 into resources to power tomorrow's industries.
GreyBird Ventures medical technology firm and invests in companies developing products for precision medicine.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Seed
- Geography: United States, Germany, China
Investor stats
- Total investments: 11
- Round size: Seed $3M–$5M; Series A $3M–$16M
- Lead/follow: 91% lead, 9% follow
Portfolio highlights
- NeuroKaire — Genetika+ is revolutionzing depression treatment. Using biological, medical and genetic data, GenetikaPlus develops personalized solution for every patient to help them recover better, faster.
- Platomics — Platomics provides a regulatory compliant digital infrastructure and network for every laboratory to setup and run genetic tests.
- Angstrom Bio — We Apply Machine Learning And Novel Nucleotide Chemistry to the Diagnosis and Treatment Of Disease. Unparalleled Diagnostic Scale. Better Drugs, Faster.
KHAN Technology Transfer Fund operates as an investment firm.
Show more...Investment focus
- Industry: Biotechnology, Medical, Biopharma
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Austria, Belgium
Investor stats
- Total investments: 15
- Round size: Seed $259k–$10M; Series A $5.6M–$10M
- Lead/follow: 53% lead, 47% follow
Portfolio highlights
- iDEL Therapeutics — iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells through a unique, pan-cancer uptake mechanism.
- KyDo Therapeutics — KyDo Therapeutics is a biotechnology company that develops novel covalent-allosteric small molecule inhibitors.
- Revier Therapeutics — Revier Therapeutics is a biotechnology company focused on developing innovative solutions to improve human health and treat diseases.
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 738
- Round size: Seed $850k–$7M; Series A $3.1M–$31M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely still investing — raised $515M in 2022
Portfolio highlights
- Zimory — Founded in 2007, Zimory provides carrier-grade cloud infrastructure management software that allows service providers, enterprises and cloud brokers to fully leverage the power and elasticity of cloud computing. Zimory’s intelligent Cloud Suite simplifies, automates and expedites the creation, launch and management of all types of cloudenvironments – whether public, private, virtual private or hybrid. Zimory software is also a key enabler of cloud marketplaces for enterprise services, applications and infrastructure. Headquartered in Berlin, Zimory has development centers in Erfurt, Germany and Minsk, Belarus, a subsidiary office in New York City and is expanding its expertise and presence globally.
- Alteva — Alteva develops battery cells for the decarbonisation of the global transport sector, and focus on high-energy density battery cells with high safety profiles specifically designed for the aviation and heavy-duty transport sectors.
- Smartblue — Smartblue develops and runs software and processes to monitor and optimize zero emission energy systems. As a hardware independent specialist Smartblue delivers a software service for the maintenance, life-cycle management, production forecasting and remote control of photovoltaic and energy storage systems all together in one centralized “SmartControl” Operations and Control Center web application. We help our customers drive down overall operational cost through automation, smart failure detection and big data analysis on imminent defects.
gcp gamma capital partners is an independent Venture Capital investment firm, focused on financing dynamic technology companies in Austria, Germany, Switzerland and CEE countries.They seek to achieve superior returns by finding assets with substantial potential in their regional and sectoral focus areas, before they appear on the radar screenof mainstream players in terms of stage and/or initial investment size.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Series A, Seed
- Geography: Austria, United States, Germany
Investor stats
- Total investments: 29
- Round size: Seed $409k–$3M; Series A $1.3M–$8M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — last raise in 2010
Portfolio highlights
- Fatfoogoo — Building microtransaction payment systems for Developers, Publishers, and Operators
- Infoniqa Group — The Infoniqa Group combines twenty years of IT experience and a new, trend-setting business, which enables networking advantages and which corresponds to the requirements of their customers - typically international medium and large enterprises and institutions.
- GAT Microencapsulation — OMPONG188 menjadi tempat untuk mengakses halaman resmi game online melalui link alternatif bebas IP yang banyak disukai oleh para pengguna hiburan digital.
BackBone Ventures' focus are early-stage investments, primarly in the area of innovative ICT, FoodTech and disruptive technologies in DACH & Israel. Committed to achieve a positive impact for the next generation by empowering access to proficient ventures investments.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: Switzerland, Germany, Israel
Investor stats
- Total investments: 74
- Round size: Seed $966k–$4M; Pre-Seed $578k–$2.8M; Series A $5M–$105M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- eternal.ag — We help greenhouses overcome labor shortages through autonomous harvesting robots so they can keep operations running, every day, at scale.
- Immitra Bio — Developing scalable in-vivo genomic medicine for blood disorders
- NextBusiness — NextBusiness makes tools for founders in Switzerland. We build the AI-first business software infinity.swiss.
We back B2B software and life-sciences companies with limitless scalability.
Show more...Investment focus
- Industry: Software, Biotechnology, Telecommunications
- Stage:Seed, Venture - Series Unknown
- Geography: Austria, Germany
Investor stats
- Total investments: 11
- Round size: Seed $1.1M–$4.4M
- Lead/follow: 82% lead, 18% follow
Portfolio highlights
- Txture — IBM Consulting uses IBM Txture to help organizations assess application portfolios, plan cloud modernization and build data-driven transformation strategies.
- HeartBeat.bio — HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies.
- MAVOCO — We create a carrier-grade software for IoT champions, trusted by tier-1 Mobile network operators.
Entrepreneurs for Entrepreneurs
Show more...Investment focus
- Industry: Software, Information Technology, Automotive
- Stage:Seed, Series A, Series B
- Geography: Austria, Germany, Switzerland
Investor stats
- Total investments: 67
- Round size: Seed $540k–$1.2M; Series A $781k–$5.6M; Series B $4.2M–$13M
- Lead/follow: 78% lead, 22% follow
Portfolio highlights
- Diamens — Diamens is a company focused on femtech that develops a non-invasive menstrual blood-based molecular diagnostic to detect women-specific diseases like endometriosis.
- Respory — Respory provides real-time people-tracking using proprietary radar sensors, all without capturing personal data. Our scalable sensor network, powered by AI-driven algorithms, delivers precise customer journey insights, critical for in-store performance in retail.
- 2nd Cycle — 2nd Cycle creating a cost-effective, fully automated, and scalable solution for modules for a second life cycle.
Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Sweden, Norway, Austria
Investor stats
- Total investments: 34
- Round size: Series A $4.2M–$79M; Series B $4.5M–$75M; Venture - Series Unknown $2M–$29M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $168M in 2021
Portfolio highlights
- Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
- ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
- TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Private Equity, Series A
- Geography: France, United States, Germany
Investor stats
- Total investments: 187
- Round size: Series A $7M–$83M; Series B $14M–$83M; Private Equity $112M–$237M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely actively investing — fresh fund, raised $491M in 2026
Portfolio highlights
- Cyllene Therapeutics — EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.
- Inventiva Pharma — Inventiva Pharma is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical needs in the areas of fibrosis, lysosomal storage disorders and oncology.They have built a pipeline backed by a discovery engine with an extensive library ofproprietary molecules, a wholly-owned research and development facility and a team with significant expertise and deep experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging these assets and expertise, they are advancing two clinical candidates in three indications, as well as a deep pipeline of earlier stage programs.
- Rivermark Medical — Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function. Developed by urologists to reliably reduce BPH symptoms with minimal side effects.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!FCPG Affi
Show more...Investment focus
- Industry: Medical, Biotechnology, Pharmaceutical
- Stage:Venture - Series Unknown
- Geography: Austria
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases in indications with high unmet medical needs. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious, and provide a better quality of life.
Show more...Investment focus
- Industry: Health Care, Biotechnology
- Stage:Seed
- Geography: Austria
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Panoptes Pharma — PETIRGACOR open Online Apotheke menyediakan layanan pemesanan medikamente resmi dengan pengiriman cepat ke seluruh Deutschland. Cek promo obat hari ini!
venture capital
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A, Series B
- Geography: Hungary, South Korea, United States
Investor stats
- Total investments: 29
- Round size: Seed $473k–$34M; Series A $1.3M–$2.3M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- Cytocast — Imagine a world where new therapies can be discovered and developed in a fraction of what it takes now.
- Iskra — Iskra offers web3 gaming opportunities using blockchain and rewards its stakeholders based on their participation.
- On Vacation — On Vacation is a chat-based concierge service where customers may get help making reservations and getting personalized and optimal tours from travel specialists.
PONTIS Capital manages two funds with total commitments of more than EUR 60 million, and is actively investing out of its second fund, PONTIS Growth Capital II (“PGC II”). The focus of PGC II is to invest in small and medium-sized growth companies with Established technology or other competitive advantage Existing proof-of-market in marketswith growth potential,Scalable business models, andHeadquarters in the DACH region (Germany, Austria, Switzerland)
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Series A, Series B, Series C
- Geography: Austria, Germany
Investor stats
- Total investments: 5
- Lead/follow: no public data
Portfolio highlights
- evidanza — evidanza GmbH is a software provider of business intelligence solutions for reporting, planification, OLAP-analysis, risk management, costs calculations, IFRS- and USGAAP-reporting. The company is headquartered in Salching, Germany.
- SensorDynamics — SensorDynamics was a European semiconductor and MEMS company specialized in developing and manufacturing high-volume micro- and wireless semiconductor sensor products for applications in automotive, industry and high-end consumer sectors. The company was acquired by Maxim Integrated in 2011 for $164 million. SensorDynamics developed and producedcustom-made designs and standard components for use in vehicle stabilization, occupant protection, navigation systems, keyless go systems and autonomous energy generators for wireless and battery free controllers for industrial, automotive and high-end consumer application.[5] With its headquarters in Graz, Austria, SensorDynamics had offices in Italy and Germany and a worldwide sales and distribution network. The company employed about 130 people in 2011.
- EUCODIS Bioscience — EUCODIS Bioscience is an experienced enzyme engineering company, providing industrial customers with high-performing enzymes. Their customers are leaders in the chemical, the pharmaceutical, the food and feed and cosmetics industries.
IPO Beteiligungs-Management is a private equity company specialized in early stage venture investments.
Show more...Investment focus
- Industry: Sensor, Medical, Wireless
- Stage:Series B
- Geography: Austria
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- SensorDynamics — SensorDynamics was a European semiconductor and MEMS company specialized in developing and manufacturing high-volume micro- and wireless semiconductor sensor products for applications in automotive, industry and high-end consumer sectors. The company was acquired by Maxim Integrated in 2011 for $164 million. SensorDynamics developed and producedcustom-made designs and standard components for use in vehicle stabilization, occupant protection, navigation systems, keyless go systems and autonomous energy generators for wireless and battery free controllers for industrial, automotive and high-end consumer application.[5] With its headquarters in Graz, Austria, SensorDynamics had offices in Italy and Germany and a worldwide sales and distribution network. The company employed about 130 people in 2011.
- EUCODIS Bioscience — EUCODIS Bioscience is an experienced enzyme engineering company, providing industrial customers with high-performing enzymes. Their customers are leaders in the chemical, the pharmaceutical, the food and feed and cosmetics industries.
IBG Beteiligungsgesellschaft Sachsen-Anhalt is a venture capital firm makes investments in territories such as Germany and Denmark.
Show more...Investment focus
- Industry: Electronics, Software, Medical Device
- Stage:Seed, Series A
- Geography: Germany, Austria
Investor stats
- Total investments: 12
- Lead/follow: no public data
Portfolio highlights
- Livil — Livil provides a toolkit for designing and delivering flexible employee benefits, including lifestyle, dental, and vision plans.
- Wingfield — Wingfield develops a system intended to transform any tennis court in the world into a smart court. The system is a combination of hardware and artificial intelligence and keeps track of the score, analyzes strokes and gives personal feedback right after matches or practice sessions and the system only costs a fraction of a professional system andis easily set up, enabling players to get the same game analytics as the professionals do.
- Baby Sweets — Baby Sweets provides Online shop for beautiful and unusual baby clothes and accessories.Sales of own brands made in EU as well as international brands.
Investing in the ReGeneration
Show more...Investment focus
- Industry: Agriculture, Biotechnology, Farming
- Stage:Seed, Series A, Series B
- Geography: United States, Austria, United Kingdom
Investor stats
- Total investments: 19
- Lead/follow: no public data
Portfolio highlights
- Anthrogen — Anthrogen is a Biotechnology Research firm using bacteria and enzymes for reducing carbon in the air by transforming it into chemicals.
- Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
- Differential Bio — Differential Bio is integrating scale-down experiments with AI-based modeling to optimize how industry-relevant microbes grow ("biomass fermentation") and produce ("precision fermentation"). By optimizing bioprocesses and growth conditions, the company is not only increasing their clients' R&D efficiency but alsodramatically improving bioproduction outcomes such as yield, cost efficiency, and product quality.
HBM Partners focuses on venture, growth and buy-out financings of private companies as well as investments in public companies.The HBM funds invest in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. Their team supports the growth of the portfolio companies through allstages of development, focusing on adding value by leveraging its experience and HBM's world-wide network in the industry. Investments usually range between $5 million to $50 million.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series B, Series C
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 41
- Round size: Series B $7.7M–$125M; Series C $2.5M–$113M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — raised $105M in 2012
Portfolio highlights
- Dren Bio — Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.
- AtaiBeckley — We are a clinical-stage biopharmaceutical company developing new mental health treatments to transform patient outcomes.
- Mineralys Therapeutics — Evolving science is revealing the importance of aldosterone in cardio-renal-metabolic diseases.We are focused on improving outcomes for people managing hypertension, CKD and related diseases that are driven by dysregulated aldosterone. About Aldosterone
Wir wollen unser wichtigstes Erbe erhalten. Eine lebenswerte Erde.
Show more...Investment focus
- Industry: Farming, Renewable Energy, Solar
- Stage:Seed, Grant, Pre-Seed
- Geography: Switzerland, Germany, Austria
Investor stats
- Total investments: 8
- Lead/follow: no public data
Portfolio highlights
- Planeteers — We capture CO2 in water and unleash the potential of the oceans as the largest carbon sink on our planet.
- Infrascreen — The transparent aluminium screen for extra energy-savings in greenhouses. Thanks to it's low-e coating, it saves up to 20% more than a regular energy-saving screen
- Kynda — Keen 4 Greens offers a wide range of vegan products. Founded in 2019, Keen 4 Greens is based in Hamburg, Germany.
Gateway Ventures is Austria's biggest network of startup investors with currently over 4000 investors. We foster the Austrian and European startup eco-system by connecting investors and startups. Our startup portfolio covers FinTech, CleanTech, HeathTech, IT & Software, Big Data & Social Impact. We have financed >40 startups withseed fundings over € 30M+Gateway Ventures was founded in December 2015. Over 1000 investors and 200 partners are currently participating in the network, including European incubators, accelerators and VCs.https://www.gateway.ventures
Show more...Investment focus
- Industry: Software, Information Technology, Apps
- Stage:Seed, Series A
- Geography: Germany, Austria, Estonia
Investor stats
- Total investments: 21
- Lead/follow: no public data
Portfolio highlights
- Mediaire — mediaire supports radiologists with AI-based tools for MRI reporting. This enables them to make a more accurate and objective assessment even faster.
- Pilzling — Bio-Pilze direkt aus deiner Stadt.
- LipoCheck — LipoCheck is a healthtech startup that focuses on improving the diagnosis and treatment of lipedema, a condition that affects millions of women. The company offers a digital platform that serves as a support system for patients and treating physicians. LipoCheck's services include helping patients recognize lipedema and providing assistance inbecoming symptom-free. The platform was developed with the experiences of practicing doctors, product managers, and software developers. In addition to its digital services, LipoCheck also offers a range of merchandise including hoodies and shirts.
Biotechnology Investor funding in Austria at a glance
Stats across 143 deals from 169 investors.
Access all 169 investors in Austria Biotechnology startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology Investors in Austria investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 169 investors investing in Austria Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!